Overview

Definition:
-Meningitis is an inflammation of the meninges, the membranes that surround the brain and spinal cord
-It can be caused by infections (bacterial, viral, fungal, parasitic) or non-infectious inflammatory conditions
-Bacterial meningitis is a life-threatening medical emergency requiring prompt diagnosis and treatment.
Epidemiology:
-Bacterial meningitis incidence has significantly decreased with widespread vaccination against *Streptococcus pneumoniae*, *Haemophilus influenzae* type b (Hib), and *Neisseria meningitidis*
-However, it remains a major cause of morbidity and mortality, particularly in neonates and immunocompromised individuals
-Viral meningitis is more common and generally less severe.
Clinical Significance:
-Meningitis can lead to severe neurological sequelae such as hearing loss, developmental delay, seizures, and intellectual disability
-Rapid initiation of appropriate empiric antibiotic therapy, guided by age and local resistance patterns, is critical to improve outcomes and reduce mortality and long-term complications
-The role of adjunctive dexamethasone is also crucial in specific scenarios.

Clinical Presentation

Symptoms:
-Fever
-Headache
-Nuchal rigidity (stiff neck)
-Photophobia
-Altered mental status (lethargy, irritability, confusion)
-Vomiting
-Seizures
-In infants: poor feeding, hypotonia, bulging fontanelle, inconsolable crying
-In neonates: irritability, poor feeding, vomiting, apnea, seizures, temperature instability.
Signs:
-Nuchal rigidity
-Positive Kernig's sign
-Positive Brudzinski's sign
-Fever
-Tachycardia
-Tachypnea
-Altered level of consciousness
-Petechial or purpuric rash (suggestive of meningococcal meningitis)
-Papilledema (late sign).
Diagnostic Criteria:
-Diagnosis is primarily based on clinical suspicion confirmed by cerebrospinal fluid (CSF) analysis
-Typical findings in bacterial meningitis include elevated white blood cell count (predominantly neutrophils), elevated protein, and low glucose levels
-CSF Gram stain and culture are essential for identifying the causative pathogen and guiding antibiotic therapy
-Viral meningitis usually shows lymphocytic pleocytosis, normal or slightly elevated protein, and normal glucose.

Diagnostic Approach

History Taking:
-Recent illness (e.g., otitis, sinusitis, pneumonia)
-Exposure to sick contacts
-Vaccination status
-Travel history
-Underlying medical conditions (e.g., immunocompromise, neurosurgery)
-Onset and progression of symptoms
-Focal neurological deficits.
Physical Examination:
-Assessment of vital signs
-Detailed neurological examination (mental status, cranial nerves, motor and sensory function, reflexes)
-Examination for nuchal rigidity
-Assessment for Kernig's and Brudzinski's signs
-Skin examination for rash
-Funduscopic examination.
Investigations:
-Complete blood count (CBC) with differential
-Blood cultures (prior to antibiotics)
-CSF analysis via lumbar puncture: cell count and differential, protein, glucose (compare with serum glucose), Gram stain, bacterial culture and sensitivity, PCR for specific pathogens (e.g., *Streptococcus pneumoniae*, *Neisseria meningitidis*, *Haemophilus influenzae* type b, enteroviruses, herpes simplex virus)
-Consider CSF latex agglutination tests
-Imaging: CT or MRI brain may be indicated to rule out complications like abscess, hydrocephalus, or increased intracranial pressure, especially if there are focal neurological deficits or signs of herniation.
Differential Diagnosis:
-Encephalitis
-Brain abscess
-Subarachnoid hemorrhage
-Migraine
-Meningismus (secondary to systemic illness)
-Meningeal carcinomatosis or leukemia
-Viral syndromes with headache and fever.

Management

Initial Management:
-Immediate medical assessment and stabilization
-Airway, breathing, circulation (ABC) management
-Prompt initiation of empiric antibiotic therapy as soon as possible, ideally after lumbar puncture and blood cultures are obtained
-If lumbar puncture is delayed or contraindicated (e.g., signs of markedly increased intracranial pressure, coagulopathy), begin antibiotics empirically based on clinical suspicion and imaging if available
-Consider empirical acyclovir if HSV encephalitis is suspected.
Medical Management:
-Empiric antibiotics are tailored based on age, local epidemiology, and resistance patterns
-For neonates (<1 month): Ampicillin + Gentamicin (or Cefotaxime if concern for resistant Gram-negatives)
-For infants and children (1 month to 12 years): Ceftriaxone (or Cefotaxime) is typically the first choice, covering *S
-pneumoniae*, *N
-meningitidis*, and *H
-influenzae*
-If *Listeria monocytogenes* is suspected (especially in neonates or immunocompromised), add Ampicillin
-Vancomycin may be added if concern for penicillin-non-susceptible *S
-pneumoniae* or for empirical coverage in high-risk areas
-For adolescents and adults: Ceftriaxone (or Cefotaxime) + Vancomycin
-Duration of therapy typically 7-21 days depending on the pathogen
-Dexamethasone: Administer 0.15 mg/kg every 6 hours for 2-4 days, starting 15-20 minutes before or with the first dose of antibiotics, for suspected bacterial meningitis in children older than 6 weeks, particularly when caused by *S
-pneumoniae*
-Not routinely recommended for suspected meningococcal or *H
-influenzae* meningitis, or in neonates.
Surgical Management: Rarely indicated for meningitis itself, but may be required for complications such as brain abscess or hydrocephalus requiring ventriculostomy or shunting.
Supportive Care:
-Fluid and electrolyte management
-Pain and fever control
-Seizure management (e.g., benzodiazepines, levetiracetam)
-Monitoring of vital signs, neurological status, and fluid balance
-Management of complications like cerebral edema or shock
-Hearing screening for all survivors of bacterial meningitis.

Complications

Early Complications:
-Cerebral edema
-Increased intracranial pressure
-Seizures
-Hydrocephalus
-Sepsis
-Shock
-Cranial nerve palsies (especially VIIIth nerve leading to hearing loss).
Late Complications:
-Hearing loss (sensorineural)
-Developmental delay
-Intellectual disability
-Learning disabilities
-Behavioral problems
-Epilepsy
-Focal neurological deficits
-Ventriculitis
-Abscess formation.
Prevention Strategies:
-Vaccination: Pneumococcal conjugate vaccine (PCV), meningococcal conjugate vaccines (MenACWY, MenB), Hib vaccine
-Prompt diagnosis and effective antibiotic therapy
-Prophylaxis for close contacts of individuals with meningococcal meningitis (e.g., rifampicin, ciprofloxacin, ceftriaxone)
-Good hygiene practices.

Prognosis

Factors Affecting Prognosis:
-Causative pathogen (e.g., *S
-pneumoniae* and Gram-negative bacilli generally have worse prognosis than *N
-meningitidis*)
-Age of patient (neonates and elderly have poorer prognosis)
-Delay in diagnosis and treatment
-Severity of illness at presentation
-Development of complications (e.g., seizures, shock, hydrocephalus).
Outcomes:
-With prompt and appropriate treatment, mortality for bacterial meningitis can be reduced significantly (e.g., <5% in some series)
-However, a substantial proportion of survivors experience long-term neurological sequelae
-Viral meningitis usually resolves completely without sequelae.
Follow Up:
-Regular follow-up visits are essential for survivors of bacterial meningitis, including developmental assessments and audiometry for hearing loss screening
-Neurological and neurocognitive evaluation may be required depending on the severity of the illness and presence of deficits.

Key Points

Exam Focus:
-Age-based empiric antibiotic choices for bacterial meningitis
-Indications and timing of dexamethasone
-CSF findings differentiating bacterial vs
-viral meningitis
-Key pathogens by age group and their antibiotic sensitivities
-Red flags for complications and neuroimaging indications.
Clinical Pearls:
-Always consider meningitis in febrile infants and children with altered mental status
-Lumbar puncture is crucial but do not delay antibiotics if LP is contraindicated or delayed
-Dexamethasone is most beneficial when given before or with the first antibiotic dose and primarily for pneumococcal meningitis
-Watch for hearing loss and developmental issues post-bacterial meningitis.
Common Mistakes:
-Delaying empiric antibiotics while waiting for diagnostic tests
-Inappropriate antibiotic selection for age or suspected pathogen
-Forgetting to check serum glucose when interpreting CSF glucose
-Not considering dexamethasone in appropriate cases
-Underestimating the risk of hearing loss and other long-term sequelae.